|
EQS-Announcement Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. This announcement is made by Union Medical Healthcare Limited (the "Company", together with its subsidiaries, the "Group") pursuant to Rule 13.09 of The Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules") and the Inside Information Provisions (as defined in the Listing Rules) under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong). The Board believes that such increase was mainly due to (i) strong demand on medical services offered by the Group which are the essential needs of individuals and remains to be key growth driver of the Group; (ii) the Group's proactive client engagement and promotional campaigns to boost sales despite the challenging operating environment as well as a rising contribution from medical services that the Group is offering, during the Reporting Period. Sales information during National Day Golden Week Holiday The Group also announces the unaudited sales volume of the Group from 1 to 10 October 2019 recorded a decrease of no more than 9% as compared with the same period last year. The Group's respective sales performance was affected mainly due to (i) the decline of visitor arrivals from mainland China to Hong Kong; and (ii) business disruption as a result of suspension of operation of certain shopping malls, arcade and office buildings where our clinics and centres are located for multiple days during the National Day Golden Week Holiday. In encountering the current challenges in Hong Kong, the Group (i) adopted proactive client engagement to retain loyal local customers; (ii) continues to develop new medical services to fulfill the essential needs of our customers; (iii) offered additional promotions to drive new local customers or customers from medical tourism; and (iv) implemented further prudent finance management approach with proactive implementation of cost control initiatives. The Group believes that its agility will retain through our core competency in brand, services and information technology. The Board wishes to remind Shareholders and potential investors that the above data are based on the unaudited management accounts of the Group which have not been reviewed or audited by the auditors of the Company. Sales performance during the Reporting Period are affected by a series of factors, and, the operational data for the Reporting Period may not be able to reflect the overall performance for a complete Reporting Period. Shareholders and potential investors of the Company are cautioned not to unduly rely on such data and are advised to exercise caution when dealing in the shares of the Company. By Order of the Board As at the date of this announcement, the executive Directors of the Company are Mr. Tang Chi Fai, and Mr. Lee Gabriel, the non-executive Directors are Mr. Luk Kun Shing Ben and Dr. Wang David Guowei, and the independent non-executive Directors are Mr. Ma Ching Nam, Mr. Look Andrew and Mr. Lam Chi Hang Josekin. *For identification purpose only
16/10/2019 Dissemination of an Announcement, transmitted by EQS Group. |
